Organization | analyze & realize GmbH

analyze & realize GmbH Report issue

For profit Phase 3

Founded: Berlin Germany (2001)

Organization Overview

First Clinical Trial

2013

NCT01905956

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Analyze & Realize | analyze & realize GmbH

Active Ingredients

Drugs in Phase 3 Trials (1)

iqp-ak-102 (1 trial)

Drugs in Other Trials (11)

acacia (1 trial)

cholesterol (1 trial)

garlic (1 trial)

glucosanol (2 trials)

iqp-ao-101 (1 trial)

iqp-as-118 (2 trials)

iqp-as-119 (1 trial)

iqp-as-121 (1 trial)

iqp-lu-104 (1 trial)

lactase (1 trial)

litramine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Body Weight (Phase 3)

Weight Loss (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 14
# of Trial APIs: 12